May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Development of a Subretinal Drug Delivery System
Author Affiliations & Notes
  • N.R. F. Beeley
    Doheny Retina Institute, Doheny Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA
  • J.V. Rossi
    Doheny Retina Institute, Doheny Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA
  • J.M. Stewart
    Doheny Retina Institute, Doheny Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA
  • E. de Juan, Jr
    Doheny Retina Institute, Doheny Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA
  • S.E. Varner
    Doheny Retina Institute, Doheny Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA
  • Footnotes
    Commercial Relationships  N.R.F. Beeley, None; J.V. Rossi, None; J.M. Stewart, None; E. de Juan, Jr., InnoRx, Inc. I, P; S.E. Varner, InnoRx, Inc. P.
  • Footnotes
    Support  NIH EY03040, Fletcher Jones Foundation
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 475. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N.R. F. Beeley, J.V. Rossi, J.M. Stewart, E. de Juan, Jr, S.E. Varner; Development of a Subretinal Drug Delivery System . Invest. Ophthalmol. Vis. Sci. 2005;46(13):475.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To optimize a subretinal (SR) drug delivery method designed to overcome systemic toxicity and diffusion limits of larger molecules. Methods: Flexible poly(methyl methacrylate) or poly(caprolactone) or rigid Nitinol (polymer coated) filaments were implanted in the SR space of 15 rabbits. These materials can either be matrix–loaded or coated with therapeutic drugs. Rabbits underwent fundus examination, FA and OCT 1, 2 and 4 weeks postoperatively. Several surgical methods were investigated. A superior conjunctival peritomy was created, and sclerotomies were made with a 20 g MVR blade 1 mm posterior to the limbus in the superotemporal quadrant (and superonasally in eyes that underwent vitrectomy). The filament was inserted into the SR space with intraocular microforceps. A vitreous cutter and infusion line were used in rabbits that had a vitrectomy before implantation. A 25–39 g needle was used to administer SR BSS solution in rabbits that received a local retinal fluid detachment (bleb) before implantation. In some eyes a 30g needle was used to create a retinotomy before implantation; in others, the filament tip was used to puncture the retina. Results:There was no SR fluid accumulation, exudate, haemorrhage or fibrosis surrounding the device at any follow–up points. FA showed no vascular leakage. Fundus photos and OCT showed the implants in position without inflammation or migration (13/13 eyes). The flexible polymer–only filaments allowed conformal positioning in the SR space. The rigid Nitinol filaments were easiest to implant – though this was at the expense of potentially penetrating deeper tissue layers (2/6 eyes). SubR blebs minimized this problem. SubR filament implantations were initially carried out without any vitrectomy, separate retinotomy or bleb. The rabbit vitreous presented itself as an unforgiving mucous–adhesive barrier that made precise positioning of the SubR implant very difficult, but nonetheless possible (1/3 eyes). A vitrectomy before SR implantation improved surgical outcome (10/10 eyes), but a retinotomy did not. Tapered filament tips were quintessential for self–starting retinotomy inserts. Implant lengths >3 mm were hard to place SR, and part of the filament generally protruded epiretinally after the procedure. Conclusions: Best results were obtained with SubR implants that were flexible, in the range of 2–2.5 mm in length, with a tapered tip, when inserted following vitrectomy and the creation of a SubR fluid detachment.

Keywords: retina • retinal neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×